Treatment of fungal infections with ABLC in the home-care setting. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Treatment of fungal infections with ABLC in the home-care setting.

J Assoc Nurses AIDS Care. 1999 May-Jun;10(3):43-52. Unique Identifier : AIDSLINE MED/20172686
Weissmann AC


Abstract: Invasive fungal infections are an important cause of morbidity and mortality in HIV-infected individuals. The management of opportunistic infections in a home-care setting offers many psychological and economic advantages over hospitalization. Amphotericin B, the gold standard treatment for invasive fungal infections, is associated with significant adverse reactions, particularly nephrotoxicity, that make it difficult to administer as home infusion therapy. Lipid formulations of amphotericin B offer therapeutic alternatives to the parent compound with comparable efficacy, significantly lower rates of nephrotoxicity, and decreased infusion times versus the conventional form. Clinical experience with amphotericin B lipid complex injection in the treatment of fungal infections demonstrates its usefulness as an effective alternative to conventional amphotericin B in home infusion therapy.


Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Amphotericin B/*THERAPEUTIC USE Antifungal Agents/*THERAPEUTIC USE AIDS-Related Opportunistic Infections/*DRUG THERAPY/NURSING Drug Combinations Home Infusion Therapy/*METHODS Human Mycoses/*DRUG THERAPY/NURSING Patient Education Phosphatidylcholines/*THERAPEUTIC USE Phosphatidylglycerols/*THERAPEUTIC USE

KWDjournalarticlereviewreview,tutorialamphotericinb/KWDtherapeuticuseantifungalagents/KWDtherapeuticuseaids-relatedopportunisticinfections/KWDdrugtherapy/nursingdrugcombinationshomeinfusiontherapy/KWDmethodshumanmycoses/KWDdrugtherapy/nursingpatienteducationphosphatidylcholines/KWDtherapeuticusephosphatidylglycerols/KWDtherapeuticuse
000630
A0061992


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .